Avior Wealth Management’s Biogen BIIB Stock Holding History

Avior Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-111	Closed	-$17K	–	906
2024 Q4	$17K	Buy	111 +10	+10%	+$1.69K	﹤0.01%	1456
2024 Q3	$19.6K	Buy	101 +1	+1%	+$209	﹤0.01%	1381
2024 Q2	$23.2K	Sell	100 -191	-66%	-$41.5K	﹤0.01%	1313
2024 Q1	$62.7K	Buy	+291	New	+$68.2K	﹤0.01%	1150
2021 Q3	–	Sell	-10	Closed	-$3K	–	1056
2021 Q2	$3K	Hold	10	–	–	﹤0.01%	860
2021 Q1	$2K	Hold	10	–	–	﹤0.01%	898
2020 Q4	$2K	Hold	10	–	–	﹤0.01%	866
2020 Q3	$2K	Hold	10	–	–	﹤0.01%	815
2020 Q2	$2K	Sell	10 -493	-98%	-$148K	﹤0.01%	788
2020 Q1	$159K	Sell	503 -115	-19%	-$34.9K	0.03%	373
2019 Q4	$183K	Sell	618 -356	-37%	-$98.8K	0.03%	382
2019 Q3	$226K	Buy	974 +218	+29%	+$50.8K	0.04%	349
2019 Q2	$177K	Hold	756	–	–	0.03%	369
2019 Q1	$178K	Sell	756 -21	-3%	-$6.61K	0.04%	357
2018 Q4	$233K	Hold	777	–	–	0.06%	286
2018 Q3	$275K	Hold	777	–	–	0.06%	277
2018 Q2	$226K	Buy	777 +19	+3%	+$5.34K	0.05%	302
2018 Q1	$208K	Buy	758 +150	+25%	+$46.6K	0.05%	300
2017 Q4	$194K	Buy	+608	New	+$195K	0.04%	333

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Avior Wealth Management's BIIB Position: Q1 2025 in Review

Avior Wealth Management sold out of Biogen (BIIB) in Q1 2025, closing a stake of 111 shares — an estimated $17K sold.

Avior Wealth Management first reported a position in BIIB in Q4 2017 and held it in 19 quarters. The position peaked at $275K in Q3 2018. 883 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

Avior Wealth Management reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
Avior Wealth Management sold 111 Biogen shares in Q1 2025, an estimated $17K.
Avior Wealth Management first reported a position in Biogen in Q4 2017 and held it in 19 quarters.
Avior Wealth Management's Biogen position peaked at $275K in Q3 2018.
883 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.